Lung Cancer
2021 Year in Review: Non–Small-Cell Lung Cancer | December 29, 2021
Data from the CodeBreaK 100 NSCLC subset population prompted the FDA to grant sotorasib accelerated approval for patients with KRASG12C mutation–positive NSCLC.
2021 Year in Review: Non–Small-Cell Lung Cancer | December 29, 2021
Sotorasib showed encouraging anticancer activity in phase 2 of a clinical trial of patients with heavily treated advanced NSCLC.
2021 Year in Review: Non–Small-Cell Lung Cancer | December 29, 2021
Immunotherapy and targeted therapy have resulted in improved survival rates in patients with NSCLC over the past decade.
2021 Year in Review: Non–Small-Cell Lung Cancer | December 29, 2021
Multidisciplinary tumor board members work closely to make the best clinical decisions for their patients with cancer to improve patient and institutional outcomes. Their decisions should be based on the clinical data of each patient in line with their own clinical and institutional guidelines.
Web Exclusives | December 22, 2021
Recently released results using liquid biopsy shows KRAS G12C mutation in patients with NSCLC can be lost or acquired at progressive disease.
Web Exclusives | December 22, 2021
Social listening can offer investigators valuable information about unmet patient needs and concerns regarding their cancer treatment and to direct future research.
Web Exclusives | December 22, 2021
Researchers found a large underrepresentation gap among minority populations across major cancer types in clinical trials.
Web Exclusives | December 22, 2021
Improved understanding of self-care behaviors in patients with cancer who take oral anticancer medications can help healthcare professionals support patient medication adherence.
Web Exclusives | November 19, 2021
A recently released MYLUNG study found that most patients with untreated metastatic NSCLC tested for ≥1 biomarkers, but <50% of patients had ≥5 biomarker tests.
Web Exclusives | November 19, 2021
Recently released clinical trial results evaluating the effect of early integration of interdisciplinary supportive care found improvement in quality of life, mood, and nutritional status in patients with NSCLC.
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512